Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

20/12/2024 - 06:33

Dallas, TX, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform, today announced the acquisition of patent number WO 2023/086647 PCT/US2022/049857, for mushroom-derived compositions and methods of treatment. This new addition to MangoRx’s intellectual property portfolio highlights the Company’s commitment to innovative solutions that support holistic health and wellness.
Mangoceuticals Secures Patent for Novel Mushroom-Based Wellness Formulations in $32B Market